Mark Goldstone

Mark is an entrepreneurial CEO with an exceptional record of building profitable businesses both domestically and internationally. A creative and strategic leader, he combines a passion for culture and communication with a keen eye for financial detail to build robust businesses with a strong sense of identity and purpose.

Mark is currently CEO of Medikly Inc., a SaaS company that provides a unique, Big Data driven, engagement marketing platform to the healthcare marketing community.

Most recently Mark was the Worldwide President of DDB’s healthcare business, where he was responsible for a global communications business spanning 40+ offices in over 36 markets. The business covered advertising, digital, integrated communications, HCP promotion, branding, naming, design, market shaping, med ed and scientific communications.

Mark has previously held senior positions at Publicis Healthcare Communications Group where he was responsible for the global sanofi-aventis business and at Interbrand where he was CEO of their global Healthcare business.

Mark began his career as a pharmacist with the UK retail giant Boots the Chemist and later moved to clinical pharmacy at St. Georges and Kingston General Hospitals in London. It was, however, a love of writing that led him to a new career in advertising – starting as a copywriter at The General Advertising Company of London Ltd. Later, Mark and a partner, co-founded their own unique Health focused advertising agency, which was quickly acquired by WCRS. The company eventually became part of Havas.

Mark moved to New York with Havas, where he held senior positions at Robert A. Becker, Euro RSCG and Jordan McGrath Case & Partners, Euro RSCG and ultimately at Euro RSCG Worldwide Headquarters, where he helped devise and build their global healthcare business – Euro RSCG Life Worldwide.

Mark holds a BSc (Hons) in Pharmacy. He is a board member of the prestigious Galien Foundation and a board member of G3 Global Genomics Group. He is a member of the Royal Pharmaceutical Society of Great Britain and is a past Co-Chairman of New York Corporate Development for the American Diabetes Association.

    Go back


    • No sessions found